Lv31
260 积分 2022-04-20 加入
Low-grade IDH -mutant gliomas: from standard post-surgical treatments to novel IDH inhibitors
12小时前
已完结
Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors
13小时前
已完结
The T1/T2 Ratio is Associated With Resectability in Patients With Isocitrate Dehydrogenase–Mutant Astrocytomas Central Nervous System World Health Organization Grades 2 and 3
26天前
已完结
Masters athletes with abnormal cardiovascular findings: a clinical consensus statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology
1个月前
已关闭
Multiplicity Control in Clinical Trials
1个月前
已完结
Epigenetic evolution of isocitrate dehydrogenase-wildtype glioblastomas
1个月前
已完结
Refined temporal-to-frontal horn shunting for trapped temporal horn syndrome: long-term outcomes and complication management in a two-center series of 53 patients
1个月前
已关闭
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2
3个月前
已完结
Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma
4个月前
已完结
皖公网安备34019202002308
